News
Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...
1d
Zacks Investment Research on MSNMRNA Stock Up on Full FDA Nod for COVID-19 Jab in Pediatric PatientsModerna MRNA announced that the FDA has approved its supplemental biologics license application seeking approval for COVID-19 vaccine, Spikevax, for use in children aged six months to 11 years, who ...
1d
MedPage Today on MSNFDA OKs Moderna's COVID Shot for KidsPfizer's COVID vaccine (Comirnaty) is fully approved for patients ages 12 and up, and authorized for kids ages 6 months ...
Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...
Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...
As a new variant that causes 'razor blade throat' spreads, the FDA updates vaccine warnings to include information on heart ...
RFK Jr. cancels U.S. Preventive Services Task Force meeting; the Department of Health and Human Services backtracked on its claim that it would release ethics forms for new members of the Advisory ...
Discover the latest FDA warning updates for COVID vaccines including increased health risks and new restrictions for healthy ...
"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...
Pfizer has been using a softly, softly approach when it comes to promoting its COVID-19 vaccine Comirnaty. But as the NFL season kicked off this month, the Big Pharma’s marketing strategy is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results